Skip to content
Research Article Open access CC BY 4.0

Effects of Anti-inflammatory Medication on Indoleamine 2,3 Dioxygenase Activity

Shazia Dawood, Samina Bano, Sadia Sundus, Asma Aijaz, Talat Samreen, Mohsin Ali Usmani

Journal of Pharmaceutical Research International · pp. 1–5 · Published 29 Apr 2022

10.9734/jpri/2022/v34i35B36166

Abstract

Objective: To study the effects of anti-inflammatory medication on Indoleamine 2,3 dioxygenase activity. Research Design: This was an investigational study. Methodology: Eighteen fully grown albino rats separated into control and two treated sets, both treated sets were given indomethacin (50mg/1000g) orally. For acute treatment first treated set was sacrificed after 3.5 hrs & for chronic treatment second set was sacrificed after 3 days. However, control set animals were given an equivalent amount of vehicle. Results: Outcomes shows that serum Indoleamine 2,3 dioxygenase (IDO) enzyme activity was suppressed after acute treatment while serum IDO activity were increased after chronic treatment however no significant effect was seen on brain IDO. Conclusion: It is concluded that indomethacin has not shown any significant effect on brain IDO. But inhibits serum IDO activity.

Tryptophan(TRP) kynurenine(KYN) Indoleamine 2,3 dioxygenase (IDO) Mesenchymal stromal cells (MSCs) tryptophan-2,3-dioxygenase (TDO)

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.